Join
Live feed
·
NEWSReleasevia Quantisnow
Xenetic Biosciences Inc. logo

Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform

ByQuantisnow·Wall Street's wire, on your screen.
XBIO· Xenetic Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XBIO (Xenetic Biosciences Inc.) and more on Quantisnow.